Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Document › Details

GlaxoSmithKline plc. (7/20/17). "Press Release: ViiV Healthcare Shares Data from Its Innovative Portfolio with HIV Community at IAS 2017". London.

	Region	Paris
	Country	France
	Organisation	ViiV Healthcare
	Group	GSK (Group)
	Organisation 2	International AIDS Society (IAS)
	Product	dolutegravir (DTG)
	Product 2	cabotegravir
	Person	Pottage, John C., Jr. (GSK 201311 CMO of ViiV Healthcare)

Original document
accessed by [iito] on

Record changed: 2023-06-05

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for GSK (Group)

[1] GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio"....
[2] Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion"....
[3] CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA....
[4] GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London....
[5] Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London....
[6] GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London....
[7] LimmaTech Biologics AG. (7/20/23). "Press Release: GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine". Schlieren....
[8] GSK plc. (6/28/23). "Press Release: GSK Completes Acquisition of Bellus Health [For media and investors only]". London....
[9] GSK plc. (4/18/23). "Press Release: GSK Reaches Agreement to Acquire Late-stage Biopharmaceutical Company Bellus Health [For media and investors only]". London....
[10] CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]